Evotec SE (EVO)
1.56
-0.05
(-3.11%)
USD |
NASDAQ |
Oct 08, 16:00
1.56
0.00 (0.00%)
After-Hours: 20:00
Evotec Max Drawdown (5Y) : 94.17% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.17% |
| August 31, 2026 | 92.91% |
| July 31, 2026 | 92.80% |
| June 30, 2026 | 91.29% |
| May 31, 2026 | 91.29% |
| April 30, 2026 | 91.29% |
| March 31, 2026 | 91.29% |
| February 28, 2026 | 89.07% |
| January 31, 2026 | 89.07% |
| December 31, 2025 | 89.07% |
| November 30, 2025 | 89.07% |
| October 31, 2025 | 89.07% |
| September 30, 2025 | 89.07% |
| August 31, 2025 | 89.07% |
| July 31, 2025 | 89.07% |
| June 30, 2025 | 89.07% |
| May 31, 2025 | 89.07% |
| April 30, 2025 | 89.07% |
| March 31, 2025 | 89.07% |
| February 28, 2025 | 89.07% |
| January 31, 2025 | 89.07% |
| December 31, 2024 | 89.07% |
| November 30, 2024 | 89.07% |
| October 31, 2024 | 89.07% |
| September 30, 2024 | 88.84% |
| Date | Value |
|---|---|
| August 31, 2024 | 88.84% |
| July 31, 2024 | 84.66% |
| June 30, 2024 | 84.66% |
| May 31, 2024 | 82.96% |
| April 30, 2024 | 81.07% |
| March 31, 2024 | 74.02% |
| February 29, 2024 | 72.78% |
| January 31, 2024 | 70.82% |
| December 31, 2023 | 70.59% |
| November 30, 2023 | 70.59% |
| October 31, 2023 | 70.59% |
| September 30, 2023 | 70.59% |
| August 31, 2023 | 70.59% |
| July 31, 2023 | 70.59% |
| June 30, 2023 | 70.59% |
| May 31, 2023 | 70.59% |
| April 30, 2023 | 70.59% |
| March 31, 2023 | 70.59% |
| February 28, 2023 | 70.59% |
| January 31, 2023 | 70.59% |
| December 31, 2022 | 70.59% |
| November 30, 2022 | 69.65% |
| October 31, 2022 | 69.65% |
| September 30, 2022 | 68.33% |
| August 31, 2022 | 59.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Lifecore Biomedical, Inc. | 89.19% |
| Codexis, Inc. | 97.65% |
| Lonza Group AG | 59.15% |
| Quanterix Corp. | 96.26% |
| Sartorius Stedim Biotech SA | 63.42% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.45 |
| Beta (5Y) | 1.973 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 55.89% |
| Historical Sharpe Ratio (5Y) | -0.7999 |
| Historical Sortino (5Y) | -1.339 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.12% |